Laboratory Corporation of America is a diagnostics & research business based in the US. Laboratory Corporation of America shares (LH) are listed on the NYSE and all prices are listed in US Dollars. Laboratory Corporation of America employs 67,000 staff and has a trailing 12-month revenue of around $12.3 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $207.09 |
|---|---|
| 52-week range | $191.97 - $232.46 |
| 50-day moving average | $203.32 |
| 200-day moving average | $211.48 |
| Wall St. target price | $239.71 |
| PE ratio | 45.2714 |
| Dividend yield | $2.88 (1.34%) |
| Earnings per share (TTM) | $4.68 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $207.09 from 2024-07-23
| 1 week (2024-07-17) | -4.03% |
|---|---|
| 1 month (2024-06-24) | -0.44% |
| 3 months (2024-04-24) | -0.41% |
| 6 months (2024-01-24) | -7.28% |
| 1 year (2023-07-24) | -5.36% |
|---|---|
| 2 years (2022-07-22) | -15.93% |
| 3 years (2021-07-23) | 283.77 |
| 5 years (2019-07-24) | 16.28% |
Valuing Laboratory Corporation of America stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Laboratory Corporation of America's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Laboratory Corporation of America's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 45x. In other words, Laboratory Corporation of America shares trade at around 45x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Laboratory Corporation of America's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.4827. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Laboratory Corporation of America's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Laboratory Corporation of America's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.6 billion.
The EBITDA is a measure of a Laboratory Corporation of America's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $12.3 billion |
|---|---|
| Operating margin TTM | 10.17% |
| Gross profit TTM | $4.4 billion |
| Return on assets TTM | 3.76% |
| Return on equity TTM | 4.37% |
| Profit margin | 3.52% |
| Book value | $94.42 |
| Market Capitalization | $17.9 billion |
TTM: trailing 12 months
Dividend payout ratio: 20.34% of net profits
Recently Laboratory Corporation of America has paid out, on average, around 20.34% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.34% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Laboratory Corporation of America shareholders could enjoy a 1.34% return on their shares, in the form of dividend payments. In Laboratory Corporation of America's case, that would currently equate to about $2.88 per share.
While Laboratory Corporation of America's payout ratio might seem low, this can signify that Laboratory Corporation of America is investing more in its future growth.
Laboratory Corporation of America's most recent dividend payout was on 11 June 2024. The latest dividend was paid out to all shareholders who bought their shares by 27 May 2024 (the "ex-dividend date").
Laboratory Corporation of America's shares were split on a 1164:1000 basis on 2 July 2023. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1164 shares. This wouldn't directly have changed the overall worth of your Laboratory Corporation of America shares – just the quantity. However, indirectly, the new 14.1% lower share price could have impacted the market appetite for Laboratory Corporation of America shares which in turn could have impacted Laboratory Corporation of America's share price.
Over the last 12 months, Laboratory Corporation of America's shares have ranged in value from as little as $191.97 up to $232.4647. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Laboratory Corporation of America's is 1.033. This would suggest that Laboratory Corporation of America's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Labcorp Holdings Inc. operates as a laboratory services company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. .
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
Learn the basics of put options: what they are, how they work and a few examples.
A deep dive into the highlights and limitations of Frec.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
These are the best day trading platforms, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out our 7 ideas for how to invest $10K to maximize your money.
Check out the best-performing ETFs so far in 2024.